Monday , 9 November 2026
Home News Sierra Leone Ex-President Chooses Nigerian Healthcare Over Political Drama
News

Sierra Leone Ex-President Chooses Nigerian Healthcare Over Political Drama

EX SIERRA LEONE PRESIDENT

In a surprising twist, ex-President of Sierra Leone, Ernest Bai Koroma, on Friday, jets off to Nigeria for medical treatment, leaving behind the political turbulence in Sierra Leone.

News had it that Koroma, masterminded a failed coup to overthrow the incumbent president, Julius Maada Bio, last November.

On this note, the government of President Bio, charged him on January 3 with four offences including treason in relation to the events in late November.

He was however, released on bail but placed on house arrest at his residence in Freetown while the matter was adjourned till January 17.

Recall that on January 3, Koroma was scheduled to relocate to Nigeria’s capital, Abuja, temporarily pending approval from President Maada Bio after failed coup plot.

But he has effectively been under house arrest since December 9, 2023.

However, Koroma landed in Abuja on Friday afternoon, welcomed by National Security Adviser Nuhu Ribadu and the president of the ECOWAS Commission Omar Alieu Touray.

News has it that ECOWAS intervention led to his temporary relocation, allowing him to spend a maximum of three months in Abuja as approved by Sierra Leone’s judicial authorities.

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

China Says It Takes Mbappé’s Apology Seriously After Mao Comment

  China has reacted to Kylian Mbappé’s apology over his comments about...

FG: Workers To Get N70,000 Monthly Transport Support From November

Federal workers will begin to receive a N70,000 monthly transport support from...

Tinubu seeks fresh $20.5bn, €1.04bn foreign loans to fund infrastructure

  In a bid to close Nigeria’s infrastructure financing gap, President Bola...

DR Congo Launches Ebola Vaccine Trial Amid Rising Outbreak

  The Democratic Republic of Congo has launched the first clinical trial...